Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
5.61
-0.29 (-4.92%)
Aug 12, 2025, 4:00 PM - Market closed
Passage Bio Employees
Passage Bio had 60 employees as of December 31, 2024. The number of employees increased by 2 or 3.45% compared to the previous year.
Employees
60
Change (1Y)
2
Growth (1Y)
3.45%
Revenue / Employee
n/a
Profits / Employee
-$947,583
Market Cap
17.50M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 60 | 2 | 3.45% |
| Dec 31, 2023 | 58 | -27 | -31.76% |
| Dec 31, 2022 | 85 | -48 | -36.09% |
| Dec 31, 2021 | 133 | 59 | 79.73% |
| Dec 31, 2020 | 74 | 54 | 270.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PASG News
- 22 hours ago - Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 4 weeks ago - Passage Bio Announces 1-for-20 Reverse Stock Split - GlobeNewsWire
- 7 weeks ago - Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update - GlobeNewsWire
- 3 months ago - Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 5 months ago - Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 5 months ago - Passage Bio to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 months ago - Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates - GlobeNewsWire
- 9 months ago - Passage Bio to Present at Guggenheim Securities Healthcare Innovation Conference - GlobeNewsWire